Key result
Amiodarone paradoxically accelerates ventricular rate to 280 bpm during AF in a WPW patient.
Why the study?
The effects of amiodarone on ventricular rate and arrhythmia risk in WPW syndrome during atrial fibrillation are not fully understood.
Does amiodarone therapy cause paradoxical malignant ventricular arrhythmias in patients with Wolff-Parkinson-White syndrome?
Case Report (n=1)
Does amiodarone therapy cause paradoxical malignant ventricular arrhythmias in patients with Wolff-Parkinson-White syndrome?
Amiodarone may paradoxically increase ventricular rate during atrial fibrillation in patients with Wolff-Parkinson-White syndrome, potentially leading to malignant ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Amiodarone may aid ventricular rate control in WPW; leaves open need for prospective trials before practice change.
The ventricular rate during rapid atrial rhythms is related in Wolff-Parkinson-White (WPW) syndrome to antegrade effective refractory period of the accessory pathways. Among the many antiarrhythmic drugs available, amiodarone is most commonly used for its large therapeutic window and very long half-life. We report a case of cardiac pre-excitation syndrome in a young male patient in whom amiodarone therapy (3000 mg/weekly) was instituted to modify the dangerous ventricular response during atrial fibrillation (shortest R-R interval 190 ms, ventricular rate 210 beats/min). Four months later, starting pharmacological treatment, a new electrophysiological study documented a malignant ventricular arrhythmia: during atrial fibrillation the minimum R-R interval was 160 ms and the ventricular rate 280 beats/min. Finally, the possible mechanism of paradoxical effect observed in our patient is hypothesized. Amiodarone could favor conduction over the accessory pathways by slowing or blocking conduction into the atrioventricular node and decreasing concealed retrograde conduction into the accessory bypass tract by normally conducted beats.
No takes yet. Share an insight, caveat, or question.
Perticone et al. (1987) conducted a case report in Wolff-Parkinson-White (WPW) syndrome (n=1). Amiodarone was evaluated on Ventricular rate and minimum R-R interval during atrial fibrillation. Amiodarone therapy in a young male with WPW syndrome paradoxically worsened ventricular response during atrial fibrillation, increasing ventricular rate from 210 to 280 beats/min.
Synapse has enriched 10 related papers. Consider them for comparative context: